CD8A and malaria: falciparum</i> antigens (CSP, AMA1 and TRAP), focusing on their potential for inclusion in a globally effective multi-epitope malaria vaccine.<h4>Methodology</h4>Sixteen experimentally validated CD8<sup>+</sup> T cell epitopes, together with the HLA typing data of study participants were curated from our previously published work.